Investment in Associates - Schedule of Fair Value of the Investment (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Schedule of Fair Value of the Investment [Abstract] | |||
| Balance at beginning | $ 952 | $ 781 | |
| Investment following achievement of first milestone | $ 400 | ||
| Equity losses from investment in MitoCareX | (500) | (429) | (210) |
| Investment in 2025 | 43 | ||
| Sale of investment in MitoCareX | (495) | ||
| Balance at ending | 952 | $ 781 | |
| Investment following achievement of second milestone | $ 600 | ||
| X | ||||||||||
- Definition The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The cash inflow from sales of investments accounted for using the equity method. [Refer: Investments accounted for using equity method] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of investment following achievement of first milestone. No definition available.
|
| X | ||||||||||
- Definition Investment following achievement of second milestone. No definition available.
|
| X | ||||||||||
- Definition The amount of investment. No definition available.
|